We can't find the internet
Attempting to reconnect
28020.1 IP-LS
28020.1 IP-LS
Résumé
Diagnose von Entzündungskrankheiten mittels neuartiger molekularer Binder
Textes supplémentaires
Abstract
BÜHLMANN develops an early diagnostic test for inflammatory diseases, such as Rheumatoid Arthritis, based on high affinity molecular binders from novel academic Swiss technology platforms to support early treatment stratification, which hampers progression of chronic inflammatory diseases.
Participants
Christian-Benedikt Gerhold
Wirtschaftspartner
cbg@buhlmannlabs.ch
Bühlmann Laboratories AG CHE-107.878.027 Christian-Benedikt Gerhold Baselstrasse 55 4124 Schönenbuch BL CH
Markus Seeger
Kontaktperson
m.seeger@imm.uzh.ch
Universität Zürich Markus Seeger Gloriastrasse 30/32 8006 Zürich ZH CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2018-10-31
- Date de fin
- 2021-02-28
- Coûts totaux approuvés
- CHF 520654.00
- Section
- 60 Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- B725 Diagnostics 100.0%